WallStSmart
PALI

Palisade Bio Inc

NASDAQ: PALI · HEALTHCARE · BIOTECHNOLOGY

$2.00
+3.63% today

Updated 2026-04-30

Market cap
$328.54M
P/E ratio
P/S ratio
11.78x
EPS (TTM)
$-0.30
Dividend yield
52W range
$1 – $3
Volume
4.1M

Palisade Bio Inc (PALI) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
6 of 8
Last 8 quarters
Avg EPS surprise
+33.2%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
+91.9%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
+3.2%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
+8.3%
2025-11-10
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-25$-0.06-97.2%$2.00$1.96-2.0%
2025-11-10$-0.38+30.9%$1.68$1.82+8.3%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.03$-0.06-97.2%
2025-09-30$-0.55$-0.38+30.9%
2025-06-30$-0.79$-0.58+26.6%
2025-03-31$-0.81$-0.47+42.0%
2024-12-31$-1.99$-0.69+65.3%$4000.00-101.6%
2024-09-30$-3.35$-2.32+30.6%
2024-06-30$-2.93$-3.32-13.3%
2024-03-31$-4.80$-4.59+4.4%
2023-12-31$-5.17$-6.45-24.8%$-250000.00
2023-09-30$-0.39$-0.44-12.8%
2023-06-30$-0.45$-0.53-17.8%
2023-03-31$-0.72$-0.54+25.0%$250000.00

Frequently asked questions

Has Palisade Bio Inc beaten earnings estimates?
Palisade Bio Inc has beaten Wall Street EPS estimates in 6 of its last 8 quarterly reports, with an average EPS surprise of +33.2% over the last 3 quarters.
How does PALI stock react to earnings?
PALI stock has moved an average of +3.2% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.